Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gene VII type newcastle disease marker vaccine strain as well as preparation method and application thereof

A technology for Newcastle disease and vaccine strains, applied in the field of vaccine genetic engineering, can solve problems that are not involved in the development of Newcastle disease marked vaccines

Active Publication Date: 2020-12-22
INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are certain reports in the literature about Newcastle disease marker vaccine and reverse genetic manipulation technology, but none of them involve the research and development of Newcastle disease marker vaccine by gene replacement

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene VII type newcastle disease marker vaccine strain as well as preparation method and application thereof
  • Gene VII type newcastle disease marker vaccine strain as well as preparation method and application thereof
  • Gene VII type newcastle disease marker vaccine strain as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0030] The present invention also provides a preparation method of the gene type VII Newcastle disease marker vaccine strain Paramyxovirus type II rY2-HB strain, comprising the following steps: a. Constructing the transcription plasmid of the serotype 2 avian paramyxovirus Y2 strain; b. The extracellular domains of the F and HN genes in the Y2 strain transcription plasmid were replaced with the F and HN gene extracellular domains of the gene VII type Newcastle disease virus HB0901 strain respectively; c. the transcription plasmid after the extracellular domain replacement was combined with three auxiliary plasmids The host cells were transfected to obtain the genotype VII Newcastle disease marker vaccine strain Paramyxovirus type II rY2-HB strain. The whole genome gene sequence of the avian paramyxovirus type 2 Y2 strain is SEQ ID NO:3.

[0031] The present invention also provides the application of the gene VII type Newcastle disease marker vaccine strain paramyxovirus type II ...

Embodiment 1

[0033] The whole genome transcription plasmid construction of embodiment 1 avian paramyxovirus type 2 (APMV-2) Y2 strain

[0034] Download the whole genome sequences of 12 strains of avian paramyxovirus type 2 in GenBank, the accession numbers are KT071756, KT071757, KT071755, HQ896023, HQ896024, EU338414, HM159993, HM159994, HM159995, LC187305, LC187323 and NC039. After comparing and analyzing the nucleotide sequences of these sequences, the relatively conservative F8 strain (HQ896023) was selected as a template, and 10 unique amino acids in the genome of the strain were mutated into a consensus sequence shared by other strains (T 1440 C, C 2142 T,T 2709 C, C 5552 T,A 6397 G,A 6868 G, G 7768 T,A 11753 C, G 14409 A,T 14480 C), obtaining the whole genome sequence of a new strain of paramyxovirus Y2 strain. Through the method of gene synthesis and cloning, the whole genome plasmid of Y2 strain was constructed. The plasmid contains the whole genome sequence of Y2 strain...

Embodiment 2r

[0039] Whole-genome transcription plasmid construction and virus rescue of embodiment 2rY2-HB strain

[0040] Using the recombinant plasmid pY2 as a template, the extracellular domains of the F and HN genes of the Y2 strain were replaced by the extracellular domains of the F and HN genes of the NDV gene type VII HB0901 strain by the In-fusion method. The specific replacement positions are as follows: the ectodomain (1-1506nt) of the F gene of the NDV HB0901 strain replaces the ectodomain (1-1455nt) of the F gene of the Y2 strain, and the ectodomain (139-1713nt) of the HN gene of the NDV HB0901 strain replaces the HN gene of the Y2 strain Extracellular domain of the gene (130-1740nt). See the construction diagram Figure 4 . The specific construction scheme is as follows.

[0041] 2.1 PCR amplification of extracellular domains of F and HN genes of Newcastle disease virus HB0901 strain

[0042] Taking the allantoic fluid of chicken embryos of Newcastle disease virus HB0901 s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a gene VII type Newcastle disease marker vaccine strain as well as a preparation method and application thereof. A reverse genetic manipulation technology is utilized, a wholegenome transcription plasmid of a serum type 2 avian paramyxovirus Y2 strain is used as a skeleton, extracellular domains of F and HN genes of the serum type 2 avian paramyxovirus Y2 strain are respectively replaced with extracellular domains of F and HN genes of a gene VII Newcastle disease virus strain, and a recombinant chimeric virus is obtained through virus rescue. The vaccine strain is preserved in China Center for Type Culture Collection (CCTCC), and the preservation number is CCTCC NO: 202052. The chimeric virus can be used for prevention and control of the main epidemic gene VII Newcastle disease in China. Meanwhile, the chimeric virus does not contain a Newcastle disease virus NP protein, and virus aiming at a Newcastle disease antibody NP protein cannot be generated after chickens are immunized. The rY2-HB vaccine strain immunized chicken flocks are subjected to antibody detection by a conventional Newcastle disease virus NP antibody ELISA detection method, NP antibody generated by clinical wild strains can be specifically detected, vaccine interference generated by antibody strains is eliminated, and monitoring and purification of Newcastle disease are facilitated.

Description

technical field [0001] The invention belongs to the field of vaccine genetic engineering, in particular to a gene type VII Newcastle disease marker vaccine strain paramyxovirus type II rY2-HB strain and a preparation method thereof. More specifically, the present invention relates to the use of reverse genetic manipulation technology to replace the ectodomains of the F and HN genes of the serotype 2 avian paramyxovirus Y2 strain with the ectodomains of the F and HN genes of the gene VII Newcastle disease virus strain, Obtain chimeric virus rY2-HB strain, and the application of this strain in gene VII Newcastle disease marker vaccine. Background technique [0002] Newcastle disease (ND) is a highly contagious disease of poultry caused by Newcastle disease virus (NDV), which seriously endangers the global poultry industry. Its typical symptoms are high fever, dyspnea, diarrhea, nervous disturbance, mucosal and serosal hemorrhage. The prevention and control of ND in my countr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N7/01C12N15/85G01N33/569G01N33/68A61K39/17A61P31/14
CPCA61K39/12A61K2039/5256A61K2039/552A61P31/14C07K14/005C12N7/00C12N15/85C12N2760/18021C12N2760/18122C12N2760/18134G01N33/56983G01N33/6854G01N2333/125G01N2469/20
Inventor 卢琴温国元王国康邵华斌罗青平商雨王红琳罗玲张蓉蓉汪宏才张腾飞张文婷
Owner INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products